Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 8K filed

Rule 24b-2 under the Securities Exchange Act of 1934

http://www.qsllp.com/InsightIdeas/ArticleDetails/tabid/85/ArticleId/9/-strong-Keeping-it-Off-the-Record-An-Overview-of-Confidential-Treatment-Requests-strong.aspx

A request for confidential treatment made pursuant to Rule 406 of the Securities Act or Rule 24b-2 of the Exchange Act must:

be sufficiently narrow, so as to only include information eligible for exemption under the FOIA;

specify the basis for the exemption (there are nine FOIA exemptions available, with "trade secrets and commercial or financial information obtained from a person and privileged or confidential" being the most invoked);

contain legal and factual analyses substantiating the exemption;

contain an affirmative representation as to the confidentiality of the information; and

indicate the duration for which the exemption is being sought.

The Commission will not generally grant a request for confidential treatment with respect to information that is specifically required to be disclosed under applicable securities laws or information that is otherwise material to investors.

Share
New Message
Please login to post a reply